Ropinirole alters gene expression profiles in SH-SY5Y cells: a whole genome microarray study.

about

Ropinirole alters gene expression profiles in SH-SY5Y cells: a whole genome microarray study.

Item

http://www.wikidata.org/entity/Q36497193

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Ropinirole alters gene express ...... whole genome microarray study.

@ast

Ropinirole alters gene express ...... whole genome microarray study.

@en

type

Item

label

Ropinirole alters gene express ...... whole genome microarray study.

@ast

Ropinirole alters gene express ...... whole genome microarray study.

@en

prefLabel

Ropinirole alters gene express ...... whole genome microarray study.

@ast

Ropinirole alters gene express ...... whole genome microarray study.

@en

P1476

Ropinirole alters gene express ...... whole genome microarray study.

@en

P2093

G Jin

http://www.w3.org/2001/XMLSchema#string

M Z Zhu

http://www.w3.org/2001/XMLSchema#string

W D Le

http://www.w3.org/2001/XMLSchema#string

P2860

The activation of nuclear phosphoinositide 3-kinase C2beta in all-trans-retinoic acid-differentiated HL-60 cells

RIP5 is a RIP-homologous inducer of cell death

The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation

Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease.

Dopamine agonists and neuroprotection in Parkinson's disease.

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease.

Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs.

Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps.

Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?

P304

e4857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1414-431X20154857

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26785691

http://www.w3.org/2001/XMLSchema#string

P932

4725189

http://www.w3.org/2001/XMLSchema#string